Hysteroscopic Findings in Women Using Progesterone Only Pills (Minipills)

NCT05024604 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2021-08-27

No results posted yet for this study

Summary

Hysteroscopic findings in women using progesterone only pills (minipills) :A Prospective cohort study.

Conditions

  • Women Health
  • Contraception

Interventions

DRUG

Progesterone Only Product in Oral Dose Form

mini pills as a contraceptive method

OTHER

office hysterscopy

office hysteroscoy

Sponsors & Collaborators

  • Samuel Gendy

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-09-01
Completion
2022-12-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05024604 on ClinicalTrials.gov